Vifor Pharma Ltd.
Vifor Pharma Ltd., a leading global pharmaceutical company headquartered in Switzerland (CH), specialises in iron deficiency and nephrology. Founded in 2000, Vifor Pharma has established itself as a key player in the industry, focusing on innovative therapies that address critical health needs. The company operates extensively across Europe, North America, and Asia, delivering high-quality products that enhance patient outcomes. Vifor Pharma's core offerings include intravenous iron therapies and treatments for chronic kidney disease, distinguished by their efficacy and safety profiles. The company has achieved notable milestones, including strategic partnerships and a robust pipeline of products that cater to underserved patient populations. With a strong market position, Vifor Pharma continues to drive advancements in the pharmaceutical sector, committed to improving the lives of patients worldwide.
DitchCarbon Score
How does Vifor Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vifor Pharma Ltd.'s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vifor Pharma Ltd.'s reported carbon emissions
Vifor Pharma Ltd., headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that Vifor Pharma may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set science-based targets to reduce their carbon footprint. While Vifor Pharma has not disclosed any specific initiatives or commitments, the industry trend indicates a growing focus on environmental responsibility and climate action. As the company progresses, it may adopt strategies to measure and reduce its carbon emissions, aligning with global efforts to combat climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vifor Pharma Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
